Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Tech for Wellbeing: Applications and Devices for a Better You - 2Instructions to Amplify Certifiable Experience While Chasing after an Internet Advertising Degree
- 3VPN Administrations for Online Protection
- 4New dinosaur tracks in Italy illustrate herds moving in unison
- 5Don't miss the waxing moon swing by the Beehive star cluster March 27
- Kids with smartphones by age 12 are at higher risk of health issues, study finds
- 'An incredible privilege and responsibility': Artemis 2's Christina Koch is ready to become the 1st woman to fly around the moon
- 6 Eyewear Brands Worth Purchasing
- A Time of Careful Eating: Individual Tests in Nourishment
- What to know about the hepatitis B shot — and why Trump officials are targeting it
- First stop, the Moon. Next stop, Mars? Why Nasa's mission matters
- Airport wait times won't return to normal until Congress reaches a deal to pay TSA. Here's why they still can't come to an agreement.
- Yemen's Houthis ready to join Iran war if needed, raising new shipping risk
- US FDA grants market authorization to six on! PLUS nicotine pouch products
